Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors.
Wu X, Dai M, Cui R, Wang Y, Li C, Peng X, Zhao J, Wang B, Dai Y, Feng D, Yang T, Jiang H, Geng M, Ai J, Zheng M, Liu H.
Wu X, et al. Among authors: wang y, wang b.
Acta Pharm Sin B. 2021 Mar;11(3):781-794. doi: 10.1016/j.apsb.2020.09.002. Epub 2020 Sep 7.
Acta Pharm Sin B. 2021.
PMID: 33777682
Free PMC article.